Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.

Fordham AM, Brown LM, Mayoh C, Salib A, Barger ZA, Wong M, Lim Kam Sian TCC, Hu C, Xie J, Gunther K, Trebilcock P, Terry RL, Barahona P, Ajuyah P, Sherstyuk A, Avila A, Cadiz R, Perkins CM, Gifford AJ, Mao J, Dolman MEM, Zhao A, O'Regan LP, Gorgels D, Lau LMS, Ziegler DS, Haber M, Tyrrell V, Lock RB, Cowley MJ, Nicholls W, Daly RJ, Ekert PG, Fleuren EDG

Open source

DOI: 10.1158/1535-7163.mct-25-0736
Published: 2026 Mar 19
Container: Molecular cancer therapeutics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1535-7163.mct-25-0736,
  title = {Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.},
  author = {Fordham AM and Brown LM and Mayoh C and Salib A and Barger ZA and Wong M and Lim Kam Sian TCC and Hu C and Xie J and Gunther K and Trebilcock P and Terry RL and Barahona P and Ajuyah P and Sherstyuk A and Avila A and Cadiz R and Perkins CM and Gifford AJ and Mao J and Dolman MEM and Zhao A and O'Regan LP and Gorgels D and Lau LMS and Ziegler DS and Haber M and Tyrrell V and Lock RB and Cowley MJ and Nicholls W and Daly RJ and Ekert PG and Fleuren EDG},
  year = {2026},
  journal = {Molecular cancer therapeutics},
  doi = {10.1158/1535-7163.mct-25-0736},
  url = {https://doi.org/10.1158/1535-7163.mct-25-0736}
}

RIS

TY  - JOUR
TI  - Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.
AU  - Fordham AM
AU  - Brown LM
AU  - Mayoh C
AU  - Salib A
AU  - Barger ZA
AU  - Wong M
AU  - Lim Kam Sian TCC
AU  - Hu C
AU  - Xie J
AU  - Gunther K
AU  - Trebilcock P
AU  - Terry RL
AU  - Barahona P
AU  - Ajuyah P
AU  - Sherstyuk A
AU  - Avila A
AU  - Cadiz R
AU  - Perkins CM
AU  - Gifford AJ
AU  - Mao J
AU  - Dolman MEM
AU  - Zhao A
AU  - O'Regan LP
AU  - Gorgels D
AU  - Lau LMS
AU  - Ziegler DS
AU  - Haber M
AU  - Tyrrell V
AU  - Lock RB
AU  - Cowley MJ
AU  - Nicholls W
AU  - Daly RJ
AU  - Ekert PG
AU  - Fleuren EDG
PY  - 2026
JO  - Molecular cancer therapeutics
DO  - 10.1158/1535-7163.mct-25-0736
UR  - https://doi.org/10.1158/1535-7163.mct-25-0736
ER  -

APA

AM, F., LM, B., C, M., A, S., ZA, B., M, W., TCC, L. K. S., C, H., J, X., K, G., P, T., RL, T., P, B., P, A., A, S., A, A., R, C., CM, P., AJ, G., J, M., MEM, D., A, Z., LP, O., D, G., LMS, L., DS, Z., M, H., V, T., RB, L., MJ, C., W, N., RJ, D., PG, E., & EDG, F. (2026). Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.. Molecular cancer therapeutics. https://doi.org/10.1158/1535-7163.mct-25-0736

Source records

pubmed · retrieved 2026-09-27T00:46:40.840Z
pubmed · retrieved 2026-09-27T00:46:40.840Z